[Otolaryngologist's perspective in childhood adenotonsillar hypertrophy]
- PMID: 29871036
- DOI: 10.13201/j.issn.1001-1781.2016.06.007
[Otolaryngologist's perspective in childhood adenotonsillar hypertrophy]
Abstract
The hypertrophy of adenoid and tonsillar is the most common cause of obstructive sleep apnea hypopnea syndrome(OSAHS) in children, which require early diagnosis and standardized treatment to improve behavior, attention and cognitive abilities. Adenotonsillectomy is the primary treatment for pediatric OSAHS with adenotonsillar hypertrophy. Meanwhile, the interest in antiinflammatory agents, such as intranasal corticosteroids and leukotriene antagonists, for childhood OSAHS has also increased.
Keywords: adenotonsillar hypertrophy; sleep apnea hypopnea syndrome,obstructive; treatment.
Copyright© by the Editorial Department of Journal of Clinical Otorhinolaryngology Head and Neck Surgery.
Conflict of interest statement
The authors of this article and the planning committee members and staff have no relevant financial relationships with commercial interests to disclose.
MeSH terms
LinkOut - more resources
Medical